1.Research progress on phase separation in cardiovascular diseases
Yukun XIANG ; Xuejie CAO ; Baoqi YU
Chinese Journal of Arteriosclerosis 2025;33(1):9-15
In recent years,more and more studies have found that phase separation plays an important role in the onset and progression of cardiovascular diseases.Phase separation refers to the process in which biological macromole-cules,such as proteins and nucleic acids,spontaneously segregate into concentrated and diluted phases under certain con-ditions.This process creates distinct functional compartments within cells and is involved in various cellular biological functions.The driving forces of phase separation include multivalent interactions such as electrostatic interactions,hydro-phobic interactions,and π-π stacking.Key protein regions that promote phase separation include intrinsically disordered regions,low complexity domains,folded domains,and nucleic acid binding domains.This article reviews recent progress in understanding the role of phase separation in cardiovascular diseases,including heart failure,myocardial fibrosis,and atherosclerosis,with a particular focus on the last five years of research.Future studies should aim to elucidate the specif-ic mechanisms of phase separation in cardiovascular diseases and explore its potential as a therapeutic target.
2.Value of Serum miR-196b-5p and miR-199a-3p Levels in Diagnosis of Non-small Cell Lung Cancer
Fuquan ZHANG ; Jinming CAO ; Xuejie WU
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2025;54(5):702-709,725
Objective To investigate the value of serum miR-196b-5p and miR-199a-3p levels in the diagnosis of non-small cell lung cancer(NSCLC).Methods A total of 202 patients with NSCLC admitted to Nantong First People's Hospital from January 2022 to March 2024 were retrospectively selected as the study objects,and 195 healthy subjects in the same period were selected as the controls.General baseline data and pathological features of NSCLC patients were collected.The expression levels of serum miR-196b-5p and miR-199a-3p were analyzed by quantitative reverse transcription polymerase chain reaction.The cor-relation between the expression levels of miR-196b-5p and miR-199a-3p and the concentration of cytokeratin 19 fragment anti-gen 21-1(Cyfra21-1)was analyzed by Pearson's correlation analysis.According to the mean expression levels of miR-196b-5p and miR-199a-3p,NSCLC patients were divided into high and low expression groups,and their clinical baseline and pathological characteristics were analyzed.Receiver operating characteristic(ROC)curves were drawn to analyze the diagnostic efficacy of se-rum Cyfra21-1,miR-196b-5p,miR-199a-3p and their combination in patients with NSCLC.Results Compared with the control group,the expression level of miR-196b-5p was increased and the expression level of miR-199a-3p was decreased in patients with NSCLC.Compared with stage Ⅰ/Ⅱ patients,the serum relative expression level of miR-196b-5p in stage Ⅲ/Ⅳ patients was significantly increased,and the relative expression level of miR-199a-3p was significantly decreased(all P<0.01).Serum miR-196b-5p levels in NSCLC patients were positively correlated with Cyfra21-1,and serum miR-199a-3p levels were negatively correlated with Cyfra21-1(all P<0.01).The expression differences of miR-196b-5p and miR-199a-3p were correlated with fam-ily history,pathological stage,tumor size,Cyfra21-1 level and lymph node metastasis of NSCLC patients(all P<0.05).The are-a-under-the-curve(AUC)of serum miR-196b-5p level for the diagnosis of NSCLC was 0.882(sensitivity 75.25%,specificity 95.38%),and the AUC of serum miR-199a-3p level for the diagnosis of NSCLC was 0.857(sensitivity 68.32%,specificity 88.21%).The AUC of traditional biomarker Cyfra21-1 in the diagnosis of NSCLC patients was 0.818(sensitivity 63.86%,spe-cificity 87.18%).The diagnostic efficacy of the combined detection of miR-196b-5p and miR-199a-3p was significantly higher than that of serum Cyfra21-1(P<0.01),miR-196b-5p(P<0.01)and miR-199a-3p(P<0.01)alone in patients with early stage(stage Ⅰ/Ⅱ)NSCLC.Conclusion The expression level of serum miR-196b-5p in NSCLC patients is significantly increased,and the expression level of miR-199a-3p is decreased,and the combined detection of miR-196b-5p and miR-199a-3p has a high effi-ciency in the diagnosis of NSCLC.
3.Value of Serum miR-196b-5p and miR-199a-3p Levels in Diagnosis of Non-small Cell Lung Cancer
Fuquan ZHANG ; Jinming CAO ; Xuejie WU
Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 2025;54(5):702-709,725
Objective To investigate the value of serum miR-196b-5p and miR-199a-3p levels in the diagnosis of non-small cell lung cancer(NSCLC).Methods A total of 202 patients with NSCLC admitted to Nantong First People's Hospital from January 2022 to March 2024 were retrospectively selected as the study objects,and 195 healthy subjects in the same period were selected as the controls.General baseline data and pathological features of NSCLC patients were collected.The expression levels of serum miR-196b-5p and miR-199a-3p were analyzed by quantitative reverse transcription polymerase chain reaction.The cor-relation between the expression levels of miR-196b-5p and miR-199a-3p and the concentration of cytokeratin 19 fragment anti-gen 21-1(Cyfra21-1)was analyzed by Pearson's correlation analysis.According to the mean expression levels of miR-196b-5p and miR-199a-3p,NSCLC patients were divided into high and low expression groups,and their clinical baseline and pathological characteristics were analyzed.Receiver operating characteristic(ROC)curves were drawn to analyze the diagnostic efficacy of se-rum Cyfra21-1,miR-196b-5p,miR-199a-3p and their combination in patients with NSCLC.Results Compared with the control group,the expression level of miR-196b-5p was increased and the expression level of miR-199a-3p was decreased in patients with NSCLC.Compared with stage Ⅰ/Ⅱ patients,the serum relative expression level of miR-196b-5p in stage Ⅲ/Ⅳ patients was significantly increased,and the relative expression level of miR-199a-3p was significantly decreased(all P<0.01).Serum miR-196b-5p levels in NSCLC patients were positively correlated with Cyfra21-1,and serum miR-199a-3p levels were negatively correlated with Cyfra21-1(all P<0.01).The expression differences of miR-196b-5p and miR-199a-3p were correlated with fam-ily history,pathological stage,tumor size,Cyfra21-1 level and lymph node metastasis of NSCLC patients(all P<0.05).The are-a-under-the-curve(AUC)of serum miR-196b-5p level for the diagnosis of NSCLC was 0.882(sensitivity 75.25%,specificity 95.38%),and the AUC of serum miR-199a-3p level for the diagnosis of NSCLC was 0.857(sensitivity 68.32%,specificity 88.21%).The AUC of traditional biomarker Cyfra21-1 in the diagnosis of NSCLC patients was 0.818(sensitivity 63.86%,spe-cificity 87.18%).The diagnostic efficacy of the combined detection of miR-196b-5p and miR-199a-3p was significantly higher than that of serum Cyfra21-1(P<0.01),miR-196b-5p(P<0.01)and miR-199a-3p(P<0.01)alone in patients with early stage(stage Ⅰ/Ⅱ)NSCLC.Conclusion The expression level of serum miR-196b-5p in NSCLC patients is significantly increased,and the expression level of miR-199a-3p is decreased,and the combined detection of miR-196b-5p and miR-199a-3p has a high effi-ciency in the diagnosis of NSCLC.
4.Research progress on phase separation in cardiovascular diseases
Yukun XIANG ; Xuejie CAO ; Baoqi YU
Chinese Journal of Arteriosclerosis 2025;33(1):9-15
In recent years,more and more studies have found that phase separation plays an important role in the onset and progression of cardiovascular diseases.Phase separation refers to the process in which biological macromole-cules,such as proteins and nucleic acids,spontaneously segregate into concentrated and diluted phases under certain con-ditions.This process creates distinct functional compartments within cells and is involved in various cellular biological functions.The driving forces of phase separation include multivalent interactions such as electrostatic interactions,hydro-phobic interactions,and π-π stacking.Key protein regions that promote phase separation include intrinsically disordered regions,low complexity domains,folded domains,and nucleic acid binding domains.This article reviews recent progress in understanding the role of phase separation in cardiovascular diseases,including heart failure,myocardial fibrosis,and atherosclerosis,with a particular focus on the last five years of research.Future studies should aim to elucidate the specif-ic mechanisms of phase separation in cardiovascular diseases and explore its potential as a therapeutic target.
5.Textual Research and Clinical Application of Chaihu Guizhi Ganjiangtang
Xuejie WANG ; Lyuyuan LIANG ; Jialei CAO ; Lan LIU ; Weixiao LI ; Yiping WANG ; Bingqi WEI ; Bingxiang MA ; Wenli SHI
Chinese Journal of Experimental Traditional Medical Formulae 2024;30(12):136-146
Chaihu Guizhi Ganjiangtang with a definite clinical effect has been widely used and recorded since the Han Dynasty. As a classic prescription of Chaihu classic formula praised by doctors ofsuccessive generations, it has been included in the Ancient Classic Prescription Catalogue (Second Batch): Han Medicine published by the National Administration of Traditional Chinese Medicine in August 2023. We carried out a bibliometric study involved 34 ancient books of traditional Chinese medicine, with 37 records including the name and composition of the prescription. This paper summarizes the source name, composition, original medicinal plant, dose, preparation method, usage, ancient and modern indications, and clinical application of Chaihu Guizhi Ganjiangtang. The results of textual research show that Chaihu Guizhi Ganjiangtang is derived from the Treatise on Febrile Diseases (Shanghanlun) written by ZHANG Zhongjing in the Han dynasty, and the original plants of medicines in this prescription are basically the same in ancient and modern times. Most records about the doses in ancient books are consistent with those in the Treatise on Febrile Diseases (Shanghanlun). The efficacy of Chaihu Guizhi Ganjiangtang is to harmonize lesser yang and resolve water retention by warming. This prescription was used to treat a variety of diseases, especially those caused by disturbance of Qi movement in the greater Yang and lesser Yang. It is now mainly used to treat the diseases in the digestive system, respiratory system, dermatology, nervous system, etc., being effective for difficult and complicated diseases. Through the excavation and combing of the ancient records of Chaihu Guizhi Ganjiangtang, this paper clarifies the key information, providing a reference for the clinical application of classical prescriptions and the development of new drugs.
6.Clinical characteristics of chronic myeloid leukemia with T315I mutation and the efficacy of ponatinib.
Chen CHEN ; Na XU ; Xuejie JIANG ; Waner WU ; Xuan ZHOU ; Liang LIU ; Jixian HUANG ; Changxin YIN ; Rui CAO ; Libin LIAO ; Dan XU ; Yuming ZHANG ; Qifa LIU ; Xiaoli LIU
Journal of Southern Medical University 2019;39(3):364-368
OBJECTIVE:
To analyze the clinical features of chronic myeloid leukemia (CML) with T315 I mutation (CML-T315I) and compare the effectiveness of different treatments.
METHODS:
We retrospectively analyzed the clinical data and outcomes of 19 patients with CML-T315I receiving different treatments. The T315 I mutations in these patients were detected by examination of BCR-ABL kinase domain (KD) mutation by RTQ-PCR and Sanger sequencing. The relapse following the treatments, defined as hematological, cytogenetic and molecular biological recurrences, were analyzed in these patients.
RESULTS:
Of the 19 patients with CML-T315I, 14 (73.7%) were in CML-CP stage at the initial diagnosis, and 13 (81.2%) were high-risk patients based on the Sokal scores. All the 19 patients were treated with TKI after the initial diagnosis, and during the treatment, 15 (78.9%) patients were found to have additional chromosomal aberrations, and 10 (52.6%) had multiple mutations; 13 (68.4%) of the patients experienced disease progression (accelerated phase/blast crisis) before the detection of T315I mutation, with a median time of 40 months (5-120 months) from the initial diagnosis to the mutation detection. After detection of the mutation, 12 patients were treated with ponatinib and 7 were managed with the conventional chemotherapy regimen, and their overall survival rates at 3 years were 83.3% and 14.2%, respectively ( < 0.001).
CONCLUSIONS
CML patients resistant to TKI are more likely to have T315I mutations, whose detection rate is significantly higher in the progressive phase than in the chronic phase. These patients often have additional chromosomal aberrations and multiple gene mutations with poor prognoses and a high recurrence rate even after hematopoietic stem cell transplantation. Long-term maintenance therapy with ponatinib may improve the prognosis and prolong the survival time of the patients.
Drug Resistance, Neoplasm
;
Fusion Proteins, bcr-abl
;
Humans
;
Imidazoles
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
Mutation
;
Pyridazines
;
Retrospective Studies
7.Evaluation on Websites of Provincial Centers for Disease Control
Huan ZHENG ; Ming WAN ; Wei WANG ; Lizhu JIN ; Xuejie DU ; Yu CAO ; Xuemei SU
Journal of Medical Informatics 2017;38(5):43-47
The paper comprehensively understands the current construction situation of 30 provincial disease control websites through scientific evaluation methods and professional evaluation indexes,and finds and analyzes the major problems.The result shows that the website construction of disease control system is in the development phase generally,information publication and online service is provided with certain foundation,but the mutual communication and website design are relatively weak links which can be greatly improved.

Result Analysis
Print
Save
E-mail